Philogen announced Option and License Agreement with Pfizer Inc. to develop and commercialize multiple antibody drug conjugates and targeted nano particles. (see full press release). Siena (Italy), December 22nd, 2014.
News & Events
Philogen announced Option and License Agreement with Pfizer Inc.
Last News & Events
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.